Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Diffusion Tensor Imaging × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 7 Breast 3 Lymphoid 2 Genitourinary 2 Tumor-Agnostic 1 Thoracic 1 Head & Neck 1 Gynecologic 1 Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

Paclitaxel 227 Carboplatin 226 Cisplatin 158 Bevacizumab 115 pembrolizumab 84 Surveys and Questionnaires 69 Cyclophosphamide 68 Radiotherapy 62 olaparib 57 Drug Therapy 51 Blood Specimen Collection 51 Hyperthermic Intraperitoneal Chemotherapy 50 Gemcitabine 50 niraparib 46 Topotecan 46 Brachytherapy 44 liposomal doxorubicin 42 Docetaxel 40 Magnetic Resonance Spectroscopy 36 Taxes 35 Cytoreduction Surgical Procedures 30 Letrozole 28 Filgrastim 28 Biopsy 28 Specimen Handling 27 durvalumab 26 Surgical Procedures, Operative 26 Doxorubicin 26 fludarabine 25 Nivolumab 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01060033 2017-04-14

MRI

Washington University School of Medicine

Phase NA Completed

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡